Kinetic analysis of RNA interference for lamin A/C in HeLa cells

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 9, 2010, Pages 623-627

  You, Sung Ju ^a   Lee, Sang Hoon ^a   Lee, Jae Seung ^a  

^a Korea University   (South Korea)

Author keywords

gene silencing; kinetic analysis; lamin A C; RNAi; siRNA

Indexed keywords

LAMIN A; LAMIN C; SMALL INTERFERING RNA;

ARTICLE; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; KINETICS; METABOLISM; METHODOLOGY; RNA INTERFERENCE; TIME;

HELA CELLS; HUMANS; KINETICS; LAMIN TYPE A; MICROSCOPY, FLUORESCENCE; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 77956271412     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq068     Document Type: Article

References (28)

1. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411: 494-498.
2. McManus MT and Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002, 3: 737-747.
3. Hannon GJ and Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 2004, 431: 371-378.
4. Caplen NJ, Parrish S, Imani F, Fire A and Morgan RA. Specific inhibition of gene expression by small double stranded RNAs in inverteberate and vertebrate systems. Proc Natl Acad Sci USA 2001, 98: 9742-9747.
5. Whitehead KA, Langer R and Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009, 8: 129-138.
6. Dorsett Y and Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 2004, 3: 318-329.
7. Kang HS, Huh YM, Kim S and Lee Dk. Isolation of RNA aptamers targeting HER-2-overexpressing breast cancer cells using cell-SELEX. Bull Korean Chem Soc 2009, 30: 1827-1831.
8. Yang YJ, Heo YS, Kim JK, Kim SY and Ahn JK. Inhibition of hepatitis B virus replication by in vitro synthesized RNA. Bull Korean Chem Soc 2005, 26: 1385-1389.
9. Jacque J-M, Triques K and Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002, 418: 435-438.
10. Choi I, Cho BR, Kim D, Miyagawa S, Kubo T, Kim JY and Park CG, et al. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing. J Biotechnol 2005, 120: 251-261.
11. Takahashi Y, Yamaoka K, Nishikawa M and Takakura Y. Moment analysis for kinetics of gene silencing by RNA interference. Biotechnol Bioeng 2005, 93: 816-819.
12. Haley B and Zamore PD. Kinetic analysis of the RNAi enzyme complex. Nat Struct Mol Biol 2004, 11: 599-606.
13. Barlett DW and Davis ME. Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live animal bioluminescent imaging. Nucleic Acids Res 2006, 34: 322-333.
14. Frock RL, Kudlow BA, Evans AM, Jameson SA, Hauschka SD and Kennedy BK. Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes Dev 2006, 20: 486-500.
15. Willis ND, Cox TR, Rahman-Casans SF, Smits K, Przyborski SA, van den Brandt P and van Engeland M, et al. Lamin A/C is a risk biomarker in colorectal cancer. PLoS ONE 2008, 3: e2988.
16. Lee JS, Green JJ, Love KT, sunshine J, Langer R and Anderson DG. Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett 2009, 9: 2402-2406.
17. Singer RH and Penman S. Messenger RNA in HeLa cells: kinetics of formation and decay. J Mol Biol 1973, 78: 321-334.
18. Puckett L and Darnell JE. Essential factors in the kinetic analysis of RNA synthesis in HeLa cells. J Cell Physiol 1977, 90: 521-534.
19. Yamaoka K, Nakagawa T and Uno T. Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm 1978, 6: 547-558.
20. Giljohann DA, Seferos DS, Prigodich AE, Patel PC and Mirkin CA. Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc 2008, 131: 2072-2073.
21. Gary DJ, Puri N and Won YY. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymerbased DNA delivery. J Control Release 2007, 121: 64-73.
22. Kim SH, Jeong JH, Lee SH, Kim SW and Park TG. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J Control Release 2006, 116: 123-129.
23. Rozema DB, Lewis DL, Wakefield DH, Wong SC, Klein JJ, Roesch PL and Bertin SL, et al. Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci USA 2008, 104: 12982-12987.
24. Kam NWS, Liu Z and Dai H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc 2005, 127: 12492-12493.
25. Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V, Hossain N and Bacallado SA, et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol 2008, 26: 561-569.
26. Qi L and Gao X. Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA. ACS Nano 2008, 2: 1403-1410.
27. Yezhelyev MV, Qi L, O'Regan RM, Nie S and Gao X. Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. J Am Chem Soc 2008, 130: 9006-9012.
28. Jeong JH, Mok H, Oh YK and Park TG. siRNA conjugate delivery systems. Bioconjug Chem 2009, 20: 5-14.